These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 8212826

  • 1. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE, Wallich R, Kramer MD, Gern L, Anderson JF, Museteanu C, Simon MM.
    Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.
    J Immunol; 2001 Jun 15; 166(12):7398-403. PubMed ID: 11390491
    [Abstract] [Full Text] [Related]

  • 3. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
    Ma J, Bulger PA, Davis DR, Perilli-Palmer B, Bedore DA, Kensil CR, Young EM, Hung CH, Seals JR, Pavia CS.
    Vaccine; 1994 Aug 15; 12(10):925-32. PubMed ID: 7975834
    [Abstract] [Full Text] [Related]

  • 4. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.
    Schaible UE, Gern L, Wallich R, Kramer MD, Prester M, Simon MM.
    Immunol Lett; 1993 May 15; 36(2):219-26. PubMed ID: 8349316
    [Abstract] [Full Text] [Related]

  • 5. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
    Aydintug MK, Gu Y, Philipp MT.
    Infect Immun; 1994 Nov 15; 62(11):4929-37. PubMed ID: 7927774
    [Abstract] [Full Text] [Related]

  • 6. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
    Lovrich SD, Callister SM, DuChateau BK, Lim LC, Winfrey J, Day SP, Schell RF.
    Infect Immun; 1995 Jun 15; 63(6):2113-9. PubMed ID: 7768589
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
    Probert WS, LeFebvre RB.
    Infect Immun; 1994 May 15; 62(5):1920-6. PubMed ID: 8168958
    [Abstract] [Full Text] [Related]

  • 9. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM, Gern L, Hauser P, Zhong W, Nielsen PJ, Kramer MD, Brenner C, Wallich R.
    Eur J Immunol; 1996 Dec 15; 26(12):2831-40. PubMed ID: 8977275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R, Siebers A, Jahraus O, Brenner C, Stehle T, Simon MM.
    Infect Immun; 2001 Apr 15; 69(4):2130-6. PubMed ID: 11254567
    [Abstract] [Full Text] [Related]

  • 13. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.
    Simon MM, Schaible UE, Kramer MD, Eckerskorn C, Museteanu C, Müller-Hermelink HK, Wallich R.
    J Infect Dis; 1991 Jul 15; 164(1):123-32. PubMed ID: 1829104
    [Abstract] [Full Text] [Related]

  • 14. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E, Tao H, Chen M, Barthold SW, Flavell RA.
    J Clin Invest; 1995 Oct 15; 96(4):1706-14. PubMed ID: 7560061
    [Abstract] [Full Text] [Related]

  • 15. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
    Fikrig E, Telford SR, Wallich R, Chen M, Lobet Y, Matuschka FR, Kimsey RB, Kantor FS, Barthold SW, Spielman A, Flavell RA.
    J Exp Med; 1995 Jan 01; 181(1):215-21. PubMed ID: 7807004
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A recombinant vaccine for Lyme disease.
    Wallich R, Kramer MD, Simon MM.
    Behring Inst Mitt; 1994 Dec 01; (95):106-8. PubMed ID: 7755503
    [Abstract] [Full Text] [Related]

  • 20. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.
    Vaccine; 1997 Dec 01; 15(6-7):739-46. PubMed ID: 9178476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.